Dual skin tests with Mycobacterium avium sensitin and PPD to detect misdiagnosis of latent tuberculosis infection

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 11, 2011, Pages 1504-1509

  Larson, E M ^a   O'Donnell, M ^b   Chamblee, S ^c   Horsburgh Jr , C Robert ^a   Marsh, B J ^d   Moreland, J D ^e   Johnson, L S ^f   Fordham Von Reyn, C ^d  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Glades Health Initiative Inc   (United States)

^d DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^e C L Brumback Health Center   (United States)

^f 2020 Company LLC   (United States)

Author keywords

LTBI; M. avium; Non tuberculous mycobacteria; Tuberculosis

Indexed keywords

DIAGNOSTIC AGENT; SENSITIN; TUBERCULIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ETHNICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LATENT TUBERCULOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TUBERCULIN TEST;

ADOLESCENT; ADULT; ANTIGENS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; DIAGNOSTIC ERRORS; FEMALE; FLORIDA; HUMANS; INFANT; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TUBERCULIN; TUBERCULIN TEST; YOUNG ADULT;

EID: 80053972865     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0015     Document Type: Article

References (24)

1. Dye C, Williams B G. The population dynamics and control of tuberculosis. Science 2010; 328: 856-861.
2. Lawn S D, Zumla A. Tuberculosis. Lancet 2011; 378: 57-72.
3. Bennett D E, Courval J M, Onorato I, et al. Prevalence of t uberculosis infection in the United States population. Am J Respir Crit Care Med 2008; 177: 348-355.
4. Centers for Disease Control and Prevention. A strategic plan for the elimination of tuberculosis in the United States. MMWR Morb Mortal Wkly Rep 1989; 38: 269-722.
5. Centers for Disease Control and Prevention. Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. MMWR Recomm Rep 1999; 48(RR-9): 1-13.
6. Geiter L, ed. Ending neglect: the elimination of tuberculosis in the United States. Washington DC, USA: National Academy Press, 2000.
7. Centers for Disease Control and Prevention. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR 2000; 49(RR-6): 2-25.
8. Duchin J S, Jereb J A, Nolan C M, Smith P, Onorato I M. Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. Clin Infect Dis 1997; 25: 661-663. (Pubitemid 127774280)
9. Griffith D E, Aksamit T, Brown-Elliott B A, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
10. Smith D T. Diagnostic and prognostic significance of the quantitative tuberculin tests: the influence of subclinical infections with atypical mycobacteria. Ann Intern Med 1967; 67: 919-946.
11. von Reyn C F, Green P A, McCormick D, et al. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative: an open study of patients with M. avium complex infection or tuberculosis. Clin Infect Dis 1994; 19: 15-20.
12. von Reyn C F, Williams D E, Horsburgh C R Jr, et al. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis 1998; 177: 730-736. (Pubitemid 28099890)
13. Magnusson M. Specificity of mycobacterial sensitins I. Am Rev Respir Dis 1961; 83: 57-68.
14. Edwards L B, Acquaviva F A, Livesay V T, Cross F W, Palmer C E. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969; 99 (Suppl): 1-132.
15. Stratford D, Chamblee S, Ellerbrock T V, et al. Integration of a participatory research strategy into a rural health survey. J Gen Intern Med 2003; 18: 586-588. (Pubitemid 36921026)
16. Magnusson M, Bleiker M A, Griep W A. Comparative intradermal reactions of young Dutch males to human purified tuberculin (PPD) and other sensitins. Acta Tuberc Pneumol Scand 1962; 42: 53-72.
17. O'Donnell M, Chamblee S, von Reyn C F, et al. Racial disparities in primary and reactivation tuberculosis in a rural community in the southeastern United States. Int J Tuberc Lung Dis 2010; 14: 733-740.
18. Reed C, von Reyn C F, Chamblee S, et al. Environmental risk factors for infection with Mycobacterium avium complex. Am J Epidemiol 2006; 164: 32-40. (Pubitemid 43946288)
19. von Reyn C F, Horsburgh C R, Olivier K N, et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001; 5: 1122-1128. (Pubitemid 34033213)
20. O'Brien R J, Geiter L J, Snider D E Jr. The epidemiology of non-tuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987; 135: 1007-1014. (Pubitemid 18021482)
21. Khan K, Wang J, Marras T. Non-tuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 2007; 176: 306-313. (Pubitemid 47195882)
22. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A. Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis 1988; 137: 1280-1284.
23. Debrunner M, Salfinger M, Brandli O, von Graevenitz A. Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis 1992; 15: 330-345.
24. von Reyn C F, Barber T W, Arbeit R D, et al. Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J Infect Dis 1993; 168: 1553-1558. (Pubitemid 23344924)